Knockdown of Galphaq to model age-related cognitive impairment
Knockdown of Galphaq to model age-related cognitive impairment
批准号:
7659285
负责人:
MICHELLE M NICOLLE
金额:
$5.96万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2011-04-30
关键词:
AdultAgeAge-associated memory impairmentAgingAgonistAlzheimer&aposs DiseaseAnimalsBindingBiologicalBiological AssayCalciumCell NucleusClinical DataCoupledCouplingDementiaDevelopmentDown-RegulationGTP-Binding ProteinsGoalsHippocampus (Brain)Impaired cognitionIndividualKnock-outKnockout MiceLearningLeftLengthLong-Term DepressionLong-Term PotentiationMaintenanceMeasuresMediatingMemoryMemory LossMemory impairmentMessenger RNAMetabotropic Glutamate ReceptorsModelingMolecularMuscarinic Acetylcholine ReceptorMuscarinicsNeuronsPlayProceduresProductionProteinsRNA InterferenceRattusReceptor ActivationReceptor SignalingRecombinant adeno-associated virus (rAAV)RegulationRoleSignal TransductionSpecificitySynaptic plasticityTechniquesTechnologyTestingTimeTransgenic MiceTransgenic OrganismsVirusWateradeno-associated viral vectorage effectage relatedagedaging braincellular transductionknock-downmild neurocognitive impairmentmotor deficitmouse modelneuronal cell bodynormal agingpre-clinicalprotein functionpublic health relevancereceptorreceptor-mediated signalingresearch studysmall hairpin RNAtherapeutic target
中文摘要
描述(由申请人提供):正常衰老中空间学习能力的下降一直与通过毒蕈碱和代谢型谷氨酸受体-G1 q/11信号转导系统介导的受体信号转导钝化相关。G1 q/11介导的信号传导在学习和记忆中的作用尚未完全确定,主要是由于药理学激动剂对与G1 q/11偶联的受体亚型的非特异性。敲除G1 q或G111(或两者)的转基因小鼠模型已被证明是有问题的,因为运动缺陷或致死性。所提出的模型将通过重组腺相关病毒(rAAV)的递送使用RNA干扰(RNAi)敲低海马中与M1毒蕈碱和I组代谢型谷氨酸受体偶联的占主导地位的G蛋白G1 q。rAAV将使海马中神经元的细胞体变性,抑制内在和投射神经元中的G1 q表达,同时使来自其他核团的传入神经中的G1 q保持完整。这些实验的结果是重要的,因为它们将定义G1 q激活在学习和记忆中的作用,并提供证据证明在衰老中观察到的受体去偶联可能与记忆障碍直接相关,而不仅仅是虚假的相关性。这种分子在空间记忆中的作用的澄清将加强其作为年龄相关记忆障碍的潜在治疗靶点的可能性。铺设说明:该项目将确定在老年学习障碍动物的细胞信号中观察到的某些相关变化是否与记忆力下降直接相关。公共卫生相关性:30%的65岁或以上的人会表现出认知能力下降的迹象,从轻度认知障碍到严重痴呆。本提案中描述的大鼠模型将提供概念证明,即先前在老年学习受损大鼠中观察到的信号改变是由于G蛋白功能的机械变化。这些大鼠研究将提供临床前数据,旨在开发潜在的治疗方法,以抵消正常的、与年龄相关的记忆力下降。
英文摘要
DESCRIPTION (provided by applicant): A decrement in spatial learning ability in normal aging has consistently been correlated with blunted receptor signaling mediated through the muscarinic and metabotropic glutamate receptor-G1q/11 signaling transduction system. The role of G1q/11-mediated signaling in learning and memory is not well established, primarily due to the non-specificity of pharmacological agonists to the receptor subtypes coupled to G1q/11. Transgenic mouse models that knocked out G1q or G111 (or both) have proven to be problematic due to motor deficits or lethality. The proposed model will knock down G1q, the predominate G-protein coupled to the M1 muscarinic and Group I metabotropic glutamate receptors, in the hippocampus using RNA interference (RNAi) via delivery by recombinant adeno-associated virus (rAAV). rAAV will transduce the cell bodies of neurons in the hippocampus, suppressing G1q expression in the intrinsic and projection neurons, while leaving G1q in afferents from other nuclei intact. The results from these experiments are significant in that they will define the role of G1q activation in learning and memory and provide proof that the receptor de-coupling observed in aging may be directly related to memory impairment and not simply a spurious correlation. The clarification of the role that this molecule plays in spatial memory will strengthen its possibility as a potential therapeutic target for age-related memory impairment. Lay description: This project will determine if certain correlational changes observed in cell signaling in the aged, learning impaired animal are directly related to memory decline. PUBLIC HEALTH RELEVANCE: Thirty percent of individuals aged 65 or older will show signs of cognitive decline ranging from mild cognitive impairment to severe dementia. The rat model described in this proposal will provide proof of concept that previously observed signaling alterations in the aged, learning impaired rat are due to mechanistic changes in G-protein function. These rat studies will provide pre-clinical data aimed at the development of potential therapies to counteract normal, age-related memory decline.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Oxidative damage and neural signaling in aging
-
批准号:6611935
-
项目类别:
-
资助金额:$26.95万
-
财政年份:2003
-
负责人:MICHELLE M NICOLLE
-
依托单位:
Oxidative damage and neural signaling in aging
-
批准号:6748138
-
项目类别:
-
资助金额:$26.95万
-
财政年份:2003
-
负责人:MICHELLE M NICOLLE
-
依托单位:
Neural Signaling in Age-related Cognitive Impairment
-
批准号:7582538
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2003
-
负责人:MICHELLE M NICOLLE
-
依托单位:
Neural Signaling in Age-related Cognitive Impairment
-
批准号:8287604
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2003
-
负责人:MICHELLE M NICOLLE
-
依托单位:
Neural Signaling in Age-related Cognitive Impairment
-
批准号:7826804
-
项目类别:
-
资助金额:$30.04万
-
财政年份:2003
-
负责人:MICHELLE M NICOLLE
-
依托单位:
Oxidative damage and neural signaling in aging
-
批准号:6900960
-
项目类别:
-
资助金额:$25.11万
-
财政年份:2003
-
负责人:MICHELLE M NICOLLE
-
依托单位:
Oxidative damage and neural signaling in aging
-
批准号:7117330
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2003
-
负责人:MICHELLE M NICOLLE
-
依托单位:
Neural Signaling in Age-related Cognitive Impairment
-
批准号:8065478
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2003
-
负责人:MICHELLE M NICOLLE
-
依托单位:
PHOSPHOINOSITIDE HYDROLYSIS AND MEMORY DECLINE IN AGING
-
批准号:6087537
-
项目类别:
-
资助金额:$3.92万
-
财政年份:1999
-
负责人:MICHELLE M NICOLLE
-
依托单位:
PHOSPHOINOSITIDE HYDROLYSIS AND MEMORY DECLINE IN AGING
-
批准号:2689069
-
项目类别:
-
资助金额:$0.1万
-
财政年份:1998
-
负责人:MICHELLE M NICOLLE
-
依托单位:
PHOSPHOINOSITIDE HYDROLYSIS AND MEMORY DECLINE IN AGING
-
批准号:2824438
-
项目类别:
-
资助金额:$3.02万
-
财政年份:1998
-
负责人:MICHELLE M NICOLLE
-
依托单位:
PHOSPHOINOSITIDE HYDROLYSIS AND MEMORY DECLINE IN AGING
-
批准号:2522780
-
项目类别:
-
资助金额:$2.44万
-
财政年份:1998
-
负责人:MICHELLE M NICOLLE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: